サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655515

体外式CO2除去装置の世界市場

Extracorporeal CO2 Removal Devices

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
体外式CO2除去装置の世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外式CO2除去装置の世界市場は2030年までに1億5,190万米ドルに達する見込み

2024年に1億730万米ドルと推定される体外式CO2除去装置の世界市場は、2030年には1億5,190万米ドルに達し、分析期間2024-2030年のCAGRは6.0%で成長すると予測されます。本レポートで分析したセグメントの1つである体外式CO2装置は、CAGR 6.6％を記録し、分析期間終了時には8,990万米ドルに達すると予測されます。ディスポーザブル分野の成長率は、分析期間中CAGR 5.4%と推定されます。

米国市場は2,940万米ドルと推定、中国はCAGR 5.5％で成長予測

米国の体外式CO2除去装置市場は、2024年に2,940万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2,360万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.1％と5.1％と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の体外式CO2除去装置市場- 主要動向と促進要因のまとめ

なぜ体外式CO2除去装置は呼吸器ケアに不可欠なのか？

体外式CO2除去（ECCO2R）デバイスは、従来の人工呼吸に代わる低侵襲の代替手段を提供することで、重篤な呼吸器疾患の管理に不可欠なものとなっています。ECCO2R装置は、患者の血液から二酸化炭素（CO2）を体外から除去することによって機能し、慢性閉塞性肺疾患（COPD）、急性呼吸窮迫症候群（ARDS）、およびCO2の蓄積が重大な懸念となるその他の肺疾患の患者を救済します。これらの装置は、肺損傷をさらに引き起こす可能性のある高圧機械換気を必要としない重症例の管理に特に有益です。CO2レベルを下げることにより、ECCO2R装置は呼吸機能を安定させ、肺の休息と回復を可能にします。また、携帯可能で使いやすいバージョンの開発により、集中治療室以外での使用も拡大しており、慢性呼吸器管理の有望なソリューションとなっています。

技術の進歩はECCO2R市場をどのように形成しているか？

医療技術の絶え間ない進歩により、ECCO2R装置はより効率的でコンパクトになり、さまざまな患者のニーズに適応できるようになってきています。革新には、合併症や感染を最小限に抑える生体適合性材料の統合や、各患者の特定の状態に合わせた正確なCO2除去を保証する高度なモニタリングシステムの使用が含まれます。ヘルスケアにおける低侵襲的アプローチの動向は、より侵入の少ないECCO2Rデバイスの設計にもつながっており、より迅速なセットアップと既存の呼吸補助システムへの統合が容易になっています。さらに、各社は病院内と在宅ケアの両方の環境に柔軟に対応できるポータブル機器の開発に注力しており、慢性疾患管理に新たな道を開いています。これらの進歩により、ECCO2R機器は呼吸器疾患の管理において極めて重要な要素となっており、ヘルスケアコストを削減しながら患者の転帰を向上させています。

ECCO2R機器の新たな応用と動向は？

ECCO2R装置の市場は、その用途が従来の病院環境を超えて拡大しつつあります。慢性呼吸器疾患の世界の増加に伴い、ECCO2R機器は、特に外来患者や在宅医療環境での長期管理ソリューションとして検討されるようになっています。医療従事者は、従来の方法では効果がなかったり、合併症のリスクがあったりするようなクリティカルケアの場面で、ECCO2R装置の採用を増やしています。さらに、COVID-19の大流行は、効果的な呼吸補助装置の必要性を浮き彫りにし、ECCO2Rの効率とアクセシビリティの向上に向けた研究開発努力を後押ししています。患者の可動性と快適性が重視されるようになったことも、メーカーを技術革新に向かわせ、緊急対応ユニットや野戦病院を含む多様なケア環境で使用できる、より軽量で汎用性の高いデバイスの生産に拍車をかけています。

ECCO2R市場の成長を促進している要因は？

ECCO2R市場の成長は、効果的なCO2管理ソリューションを必要とするCOPDやARDSなどの呼吸器疾患の有病率の増加など、いくつかの要因によって牽引されています。COVID-19パンデミックの影響も、高度な呼吸サポート技術の必要性を強調し、需要をさらに刺激しています。さらに、生体適合性が高く低侵襲のECCO2Rデバイスの開発などの技術革新が、さまざまなヘルスケア環境でのこれらのシステムの採用を促進しています。患者の嗜好や医療費削減の必要性に後押しされ、携帯型や在宅ケアの呼吸器ソリューションが推進されていることが、市場の成長をさらに加速させています。特に新興市場におけるヘルスケア・インフラへの投資と呼吸器機器の技術革新の増加は、ECCO2R分野に大きな成長機会をもたらすと期待されています。

セグメント

製品（体外式CO2マシン、ディスポーザブル、その他製品）;アクセス（静脈、動静脈）;用途（肺移植への橋渡し、急性呼吸窮迫症候群（ARDS）、慢性閉塞性肺疾患（COPD）、その他用途）;最終用途（病院、外来手術センター、診療所、その他最終用途）

調査対象企業の例（注目の44社）

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16374

Global Extracorporeal CO2 Removal Devices Market to Reach US$151.9 Million by 2030

The global market for Extracorporeal CO2 Removal Devices estimated at US$107.3 Million in the year 2024, is expected to reach US$151.9 Million by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.4 Million While China is Forecast to Grow at 5.5% CAGR

The Extracorporeal CO2 Removal Devices market in the U.S. is estimated at US$29.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$23.6 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Extracorporeal CO2 Removal Devices Market - Key Trends & Drivers Summarized

Why Are Extracorporeal CO2 Removal Devices Critical for Respiratory Care?

Extracorporeal CO2 removal (ECCO2R) devices have become vital in the management of severe respiratory conditions, offering a less invasive alternative to traditional ventilation. ECCO2R devices function by removing carbon dioxide (CO2) from the patient’s blood externally, providing relief for patients with chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and other lung disorders where CO2 accumulation is a critical concern. These devices are particularly beneficial in managing severe cases without the need for high-pressure mechanical ventilation, which can cause further lung injury. By reducing CO2 levels, ECCO2R devices help stabilize respiratory functions, allowing the lungs to rest and recover. The development of portable and user-friendly versions of these devices is also expanding their use beyond intensive care units, making them a promising solution for chronic respiratory management.

How Are Technological Advancements Shaping the ECCO2R Market?

With continuous advancements in medical technology, ECCO2R devices are becoming more efficient, compact, and adaptable to various patient needs. Innovations include integrating biocompatible materials that minimize complications and infections, and the use of advanced monitoring systems that ensure precise CO2 removal tailored to each patient’s specific condition. The trend toward minimally invasive approaches in healthcare has also led to the design of ECCO2R devices that are less intrusive, enabling quicker setup and easier integration into existing respiratory support systems. Additionally, companies are focusing on developing portable devices that offer greater flexibility for both in-hospital and home care settings, opening new avenues for chronic condition management. These advancements are making ECCO2R devices a pivotal component in the management of respiratory diseases, enhancing patient outcomes while reducing healthcare costs.

What Are the Emerging Applications and Trends in ECCO2R Devices?

The market for ECCO2R devices is expanding as their applications extend beyond traditional hospital settings. With increasing incidences of chronic respiratory diseases globally, these devices are now being explored for long-term management solutions, especially in outpatient and home-care environments. Medical practitioners are increasingly adopting ECCO2R devices for critical care scenarios where traditional methods might be ineffective or pose risks of complications. Furthermore, the COVID-19 pandemic has highlighted the need for effective respiratory support devices, boosting the research and development efforts towards improving ECCO2R efficiency and accessibility. The growing emphasis on patient mobility and comfort is also pushing manufacturers to innovate, producing lighter and more versatile devices that can be used in diverse care settings, including emergency response units and field hospitals.

What Factors Are Fueling the Growth of the ECCO2R Market?

The growth in the ECCO2R market is driven by several factors, including the increasing prevalence of respiratory diseases such as COPD and ARDS, which demand effective CO2 management solutions. The impact of the COVID-19 pandemic has also underscored the necessity for advanced respiratory support technologies, further stimulating demand. Additionally, technological innovations, such as the development of biocompatible and minimally invasive ECCO2R devices, are enhancing the adoption of these systems in various healthcare settings. The push towards portable and home-care respiratory solutions, fueled by patient preference and the need for healthcare cost reduction, is further accelerating the market’s growth. Rising investments in healthcare infrastructure and respiratory device innovation, particularly in emerging markets, are expected to create significant growth opportunities in the ECCO2R sector.

SCOPE OF STUDY:

The report analyzes the Extracorporeal CO2 Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Extracorporeal CO2 Machines, Disposables, Other Products); Access (Venovenous, Arteriovenous); Application (Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), Other Applications); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Aferetica Srl
  • Alung Technologies, Inc.
  • ESTOR S.P.A
  • Getinge AB
  • Medica SpA
  • Medtronic PLC
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Extracorporeal CO2 Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Respiratory Disorders Fueling Demand for CO2 Removal
    • Growing Adoption of Minimally Invasive Respiratory Support Technologies
    • Expansion of Intensive Care Units and Demand for Advanced Respiratory Equipment
    • Increasing Focus on Reducing Ventilator Dependency in Critical Care
    • Technological Advancements in Extracorporeal Life Support Systems
    • Rising Demand for Portable and User-Friendly CO2 Removal Devices
    • Growth in Awareness of Lung Preservation and Respiratory Support Options
    • Increased Research and Development for Efficient Gas Exchange Technologies
    • Growing Investment in Respiratory Care in Hospitals and Clinics
    • Surge in Use of CO2 Removal in Emergency and Acute Care Settings
    • Expansion of Extracorporeal Therapies in Cardiopulmonary Rehabilitation
    • Rising Demand for CO2 Removal in Pediatric and Neonatal Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Extracorporeal CO2 Removal Devices Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Extracorporeal CO2 Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Extracorporeal CO2 Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Venovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Arteriovenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Arteriovenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bridge To Lung Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bridge To Lung Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Acute Respiratory Distress Syndrome (ARDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease (COPD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Extracorporeal CO2 Removal Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Europe 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Extracorporeal CO2 Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Product - Extracorporeal CO2 Machines, Disposables and Other Products Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Product - Percentage Breakdown of Value Sales for Extracorporeal CO2 Machines, Disposables and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Access - Venovenous and Arteriovenous Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Access - Percentage Breakdown of Value Sales for Venovenous and Arteriovenous for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by Application - Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by Application - Percentage Breakdown of Value Sales for Bridge To Lung Transplant, Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Extracorporeal CO2 Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of World 15-Year Perspective for Extracorporeal CO2 Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION